Skip to main content
Orion Oyj logo

Orion Oyj — Investor Relations & Filings

Ticker · ORNAV ISIN · FI0009014377 LEI · 74370029VAHCXDR7B745 HE Manufacturing
Open in API
Filings indexed 1,138 across all filing types
Latest filing 2025-05-02 Share Issue/Capital Cha…
Country FI Finland
Listing HE ORNAV

About Orion Oyj

https://www.orion.fi/en/

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients (APIs). The company's portfolio encompasses a wide range of products, including prescription drugs, generic medications, and over-the-counter (OTC) products. In addition to its proprietary and generic product lines for both human and animal health, Orion provides contract manufacturing and packaging services to other pharmaceutical entities. The company manages the entire pharmaceutical value chain, from research and development through to production and marketing.

Recent filings

Filing Released Lang Actions
Orion Corporation: Disclosure Under..
Share Issue/Capital Change Classification · 99% confidence The document is a short press release (2169 characters) titled 'PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT' (Stock Exchange Release - Other information to be disclosed under the rules of the stock exchange). The core content explicitly states that a specific number of A-shares (301,521) were converted into B-shares, detailing the resulting total share count and voting rights. This action directly relates to a change in the company's capital structure (share classes/counts). This fits the definition of 'Share Issue/Capital Change' (SHA), which covers capital structure changes, rather than a general regulatory filing (RNS) or a financing announcement (CAP). Since it is a direct announcement of a capital structure change, SHA is the most precise fit.
2025-05-02 Finnish
Orion Corporation: Disclosure Under..
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a 'STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE' from Orion Corporation. The core content announces that 301,521 A shares were converted into B shares, resulting in a change in the total number of A and B shares and the total voting rights. This action directly relates to a change in the company's capital structure (share classes and total shares). This fits best under the 'Share Issue/Capital Change' category (SHA), as it is a formal notification of a change in the composition of the issued share capital, even though it's a conversion rather than a new issuance or buyback. It is not an earnings release, management change, or dividend notice. Given the specific nature of the announcement regarding share structure modification, SHA is the most precise fit over the general 'RNS' fallback.
2025-05-02 English
Orion Corporation: Disclosure Under..
Major Shareholding Notification Classification · 99% confidence The document is titled 'Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)' and explicitly states it is a 'PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE' (Stock Exchange Release / Major Shareholders Announcement). It details that BlackRock, Inc.'s ownership stake in Orion Oyj has crossed the 5% threshold as per the Securities Markets Act (Arvopaperimarkkinalaki). This directly corresponds to the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2025-04-25 Finnish
Orion Corporation: Disclosure Under..
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS' and details a disclosure received by Orion Corporation regarding BlackRock, Inc.'s shareholding crossing the five (5) per cent threshold, as mandated by the Securities Market Act. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing defined thresholds.
2025-04-25 English
Composition of the Nomination Commi..
Board/Management Information Classification · 99% confidence The document is a 'PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT' (Stock Exchange Release - Other information disclosed under stock exchange rules) from Orion Oyj, dated April 24, 2025. The content specifically details the composition and purpose of the company's Nomination Committee ('nimitysvaliokunnan kokoonpano'). This type of announcement, concerning the structure and appointments within the board committees, falls under governance and management information. While it relates to the board (MANG) or governance (CGR), the specific focus on committee appointments and structure aligns best with Governance Information (CGR), which covers internal rules and board structure, or potentially Management Information (MANG) due to the board context. Given the explicit mention of the committee's role in proposing board composition and remuneration, CGR (Governance Information) is the most precise fit for detailing internal governance structure elements.
2025-04-24 Finnish
Composition of the Nomination Commi..
Board/Management Information Classification · 99% confidence The document is titled 'STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE' and announces the 'Composition of the Nomination Committee of Orion Corporation'. This type of announcement, detailing the appointment of committee members (which directly relates to corporate governance and preparation for shareholder meetings/board structure), is a specific corporate disclosure. It is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with general corporate governance information or a specific regulatory disclosure that doesn't fit the other defined categories. Since it details the structure and composition of a key board committee (Nomination Committee), it falls under Governance Information (CGR). However, given the context of 'Other information disclosed according to the rules of the Exchange' and the specific nature of committee appointments, it is a specific regulatory disclosure. If CGR is interpreted broadly as governance structure, it fits. If we look at the definitions, it is not MANG (management change), but committee composition. Given the options, CGR (Governance Information) is the best fit for detailing the structure of a board committee, although RNS (Regulatory Filings) is a strong fallback for non-standard disclosures. I will classify it as CGR as it directly pertains to corporate governance structure.
2025-04-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.